KAINOS Laboratories, Inc. (TYO:4556)

Market Cap	5.22B
Revenue (ttm)	4.44B
Net Income (ttm)	82.76M
Shares Out	4.45M
EPS (ttm)	18.58
PE Ratio	63.17
Forward PE	n/a
Dividend	35.00 (3.08%)
Ex-Dividend Date	Mar 28, 2025

Volume	3,200
Average Volume	2,870
Open	1,152.00
Previous Close	1,135.00
Day's Range	1,152.00 - 1,198.00
52-Week Range	1,035.00 - 1,321.00
Beta	0.35
RSI	49.67
Earnings Date	May 9, 2025

About KAINOS Laboratories

KAINOS Laboratories, Inc. engages in the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products in Japan. It is also involved in the development, manufacture, marketing, distribution, and import/export of physical and chemical measurement instruments, and medical supplies, as well as nutrition supplements, foodstuff, animal feed, and related products. The company offers various biochemical clinical testing reagents systems, such as Aqua-auto Kainos CRE-IV Test ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1975
• Employees: 133
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4556

Financial Performance

In 2009, KAINOS Laboratories's revenue was 4.22 billion, an increase of 17.25% compared to the previous year's 3.59 billion. Earnings were 101.44 million, a decrease of -39.52%.